When did 89BIO INC (ETNB) report earnings last quarter?
89BIO INC (ETNB) last reported earnings on 11/6/2025.
NASDAQ:ETNB • US2825591033
Past quarterly earnings results for 89BIO INC (ETNB), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2025 | -0.71 | -0.50 | -42.32% | -47.92% | - | - | ||
| Q1 2025 | -0.49 | -0.51 | 3.43% | 9.26% | - | - | ||
| Q4 2024 | -1.02 | -0.79 | -29.63% | -104.00% | - | - | ||
| Q3 2024 | -1.39 | -0.65 | -112.45% | -208.89% | 546.424K | -100.00% | - | |
| Q2 2024 | -0.48 | -0.58 | 17.40% | 7.69% | - | - | ||
| Q1 2024 | -0.54 | -0.47 | -14.78% | - | - | - | ||
| Q4 2023 | -0.50 | -0.50 | 0.97% | -4.17% | - | - | ||
| Q3 2023 | -0.45 | -0.54 | 16.76% | 21.05% | - | - | ||
| Q2 2023 | -0.52 | -0.42 | -23.91% | 57.72% | - | - | ||
| Q1 2023 | -0.54 | -0.53 | -1.48% | 57.14% | - | - | ||
| Q4 2022 | -0.48 | -0.70 | 31.43% | 63.08% | - | - | ||
| Q3 2022 | -0.57 | -0.81 | 29.93% | 59.57% | - | - | ||
| Q2 2022 | -1.23 | -1.07 | -14.52% | -19.42% | - | - | ||
| Q1 2022 | -1.26 | -1.32 | 4.45% | -70.27% | - | - | ||
| Q4 2021 | -1.30 | -1.33 | 2.58% | -106.35% | - | - | ||
| Q3 2021 | -1.41 | -1.08 | -30.92% | -63.95% | - | - | ||
| Q2 2021 | -1.03 | -0.86 | -20.42% | -21.18% | - | - | ||
| Q1 2021 | -0.74 | -0.71 | -4.69% | 2.63% | - | - | ||
| Q4 2020 | -0.63 | -0.89 | 29.01% | - | - | - | ||
| Q3 2020 | -0.86 | -0.86 | -0.39% | - | - | - | ||
| Q2 2020 | -0.85 | -0.85 | 0.20% | - | - | - | ||
| Q1 2020 | -0.76 | -0.88 | 13.69% | - | - | - |
Notes
89BIO INC (ETNB) last reported earnings on 11/6/2025.
89BIO INC (ETNB) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, 89BIO INC (ETNB) has beaten EPS estimates in 1 out of 4 releases.